Redeye is only making minor changes to forecasts and valuation following the 2024/05 full year report. Q4 saw a flattish top-line on Group level, but with several markets showing healthy growth. Gross margins continued to improve, and EBIT margins (adjusted for one-offs) were significantly higher Y/Y. Systemair’s outlook remains optimistic and virtually unchanged.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/